Search | Page 9 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Platelet drug shows clinical benefits for severe, unresponsive aplastic anemia

    ... MDS. Do you have a timeline for the Phase 3 clinical trial period and how soon Eltrombopag could be possibly be ... Molecular Hematopoiesis Lab since 2000. Dr. Dunbar’s research group investigates the mechanisms by which stem cells develop ...

    Interview last updated 07/06/2012 - 3:42pm.

  2. Advances in the molecular pathology of MDS

    ... to integrate these complex findings into prevailing clinical prognostication systems and clinical practice. The frequent finding of ... and combination therapies - are the focus of intensive research and clinical trials. Reviewer Bio:  ...

    Research Review last updated 05/02/2016 - 9:44am.

  3. Leslie Pettiford, RN, MS, CCRC

    ... Position / Title:  Clinical Research Coordinator Institution:  ...

    Bio last updated 06/14/2017 - 9:07am.

  4. Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network.

    ... To address this issue, the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) convened a group of international experts in ... and propose initiatives to facilitate clinical and biologic research. Key conclusions of the working group were: (1) new patients should ...

    Research Article last updated 10/11/2011 - 5:58pm.

  5. Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

    ... BACKGROUND: The clinical presentation of myelodysplastic syndromes is highly variable ... IPSS and fatigue score from the European Organisation for Research and Treatment of Cancer quality-of-life questionnaire-core 30, ...

    Research Article last updated 11/10/2015 - 10:47am.

  6. Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS

    ... 4, 2014 Reliable clinical or molecular predictors of benefit from azacitidine therapy ... azacitidine therapy remains an unmet medical need and a top research priority. Bone Marrow Diseases:  ...

    Research Article last updated 08/04/2014 - 8:37am.

  7. Clinical Trials

    Clinical Research Educational Site Clinical research studies can offer good treatment options for some people ...

    Page last updated 03/14/2016 - 10:14am.

  8. Optimizing management of myelodysplastic syndromes post-allogeneic transplantation

    ... preemptive therapy is an important goal of current clinical research . Further strategies aiming at an improved prevention of ...

    Research Article last updated 12/05/2011 - 10:23am.

  9. Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndromes

    ... to prevent relapse, is an important goal of current clinical research . There is an urgent need for prospective randomized trials to ...

    Research Article last updated 11/05/2012 - 9:30am.

  10. Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly

    ... can influence life expectancy and treatment tolerance. Clinical trials accounting for the heterogeneity of tumor biology and ... with MDS and AML and highlights future directions for research. Bone Marrow Diseases:  ...

    Research Article last updated 12/09/2015 - 1:30pm.